MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.330
+0.110 (9.02%)
At close: Dec 22, 2025, 4:00 PM EST
1.370
+0.040 (3.01%)
Pre-market: Dec 23, 2025, 8:39 AM EST
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $49.25 million as of December 23, 2025. Its market cap has decreased by -3.27% in one year.
Market Cap
49.25M
Enterprise Value
38.36M
1-Year Change
-3.27%
Ranking
Category
Stock Price
$1.33
Market Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has decreased from $51.10M to $49.25M, a decrease of -3.62%. That is a compound annual growth rate of -1.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 45.18M | -12.77% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |